At a glance
- Originator UPSA
- Class Analgesics; Indoles
- Mechanism of Action Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 29 Feb 2000 No-Development-Reported for Pain in France (Unknown route)
- 29 May 1997 New profile
- 29 May 1997 Preclinical development for Pain in France (Unknown route)